低分子肝素对非小细胞肺癌患者凝血功能的影响

Effects of low molecular weight heparin on coagulation function in patients with non small cell lung cancer

目的:探讨低分子肝素对非小细胞肺癌患者凝血功能的影响。方法:收治非小细胞肺癌患者40例,分研究组和对照组。两组化疗方案均为DP方案,研究组加用低分子肝素治疗。结果:研究组化疗疗效优于对照组,差异有统计学意义(P<0.05);两组治疗后凝血功能及KPS评分比较,差异有统计学意义(P<0.05)。结论:低分子肝素可以改善非小细胞肺癌患者机体凝血状态,提高化疗疗效及患者基础状态。

Objective:To investigate the effect of low molecular weight heparin on coagulation function in patients with non-small cell lung cancer.Methods:40non small cell lung cancer patients in our hospital were divided into the study group and the control group.The two groups were treated with DP and the study group was treated with low molecular weight heparin(LMWH).Results:The curative effect of the study group was better than that of the control group,and the difference was statistically significant(P<0.05).The difference of coagulation function and KPS score after treatment between groups was significant(P<0.05).Conclusion:Low molecular weight heparin can improve the coagulation status of patients with non-small cell lung cancer,improve the efficacy of chemotherapy and the basic state of patients.